Faster than implementing third-party solutions,
100% on brand experience and
total control
over data and performance.
Martin Dow France is one of the most ethical pharmaceutical group of companies, We are here to improve the quality of life for the communities we serve and we focus on patients’ wellbeing and everything follow
Goualle – Champ de Lachaud
19250 Meymac
France
Pharmaceutical
500 — 1000 employees
~$30M
Founded in 1995, Martin Dow is a multinational pharmaceutical company and healthcare group, a status achieved through rigorous efforts of its management and employees.Martin Dow France Limited markets over 60 brands with more than 1000 employees countrywide. It markets research-based products and world-class branded generics which are developed, formulated and manufactured at its cGMP compliant manufacturing facility.
Pharmaceutical should be at the forefront of innovation, but their digital experiences are often stuck in the past. Martin Dow France needed to take a massive leap forward to help their constituents learn about their relationship between users and environment. Martin Dow France website had become a tangled ecosystem built over many years by many administrators. It failed to serve their clients, potential hires, and even their own team.
Our Team help their both upstream and downstream manufacturing processes, through App development and Staff Augmentation They allow manufacturers to quickly switch from one product to another, or from batch to batch, by reducing or eliminating the time required for cleaning and steaming. Single-use components also make it possible to generate biopharmaceuticals on a smaller scale, such as antibodies, proteins, vaccines, and cell treatments, which would be considerably more difficult to do otherwise.
Our Team help their both upstream and downstream manufacturing processes, through App development and Staff Augmentation They allow manufacturers to quickly switch from one product to another, or from batch to batch, by reducing or eliminating the time required for cleaning and steaming. Single-use components also make it possible to generate biopharmaceuticals on a smaller scale, such as antibodies, proteins, vaccines, and cell treatments, which would be considerably more difficult to do otherwise.